石四药集团：国家集采接续采购中，本集团共45个品种的产品拟中标

Core Viewpoint - The company, 石四药集团 (Sihuan Pharmaceutical Holdings Group Ltd), is expected to have a positive impact on its business due to the anticipated successful bids for 45 product varieties in the upcoming national centralized procurement in China scheduled for February 10, 2026 [1] Group 1: Product Categories - The 45 product varieties cover multiple therapeutic areas including anti-infection, cardiovascular system, respiratory system, digestive system, and nervous system [1]